These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2837849)

  • 1. Infection prophylaxis after organ transplantation.
    Migliori RJ; Simmons RL
    Transplant Proc; 1988 Jun; 20(3):395-9. PubMed ID: 2837849
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of infection in recipients of solid organ transplants].
    Lumbreras C; Otero JR; Aguado JM
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():77-89. PubMed ID: 9312302
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Pescovitz MD
    Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic prophylaxis during extracorporeal circulation].
    Vracun D; Pustisek S; Jelić I; Janjić I; Pasini M
    Acta Chir Iugosl; 1980; 27 Suppl 1():207-9. PubMed ID: 7424372
    [No Abstract]   [Full Text] [Related]  

  • 5. [Infectious complications after liver transplantation].
    Moncorge C; Matmar M
    Ann Radiol (Paris); 1994; 37(5):383-5. PubMed ID: 7993025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects and management of cytomegalovirus infection.
    Sissons JG; Carmichael AJ
    J Infect; 2002 Feb; 44(2):78-83. PubMed ID: 12076065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of selective bowel decontamination as infection prevention after liver transplantation.
    Rosman C; Klompmaker IJ; Bonsel GJ; Bleichrodt RP; Arends JP; Slooff MJ
    Transplant Proc; 1990 Aug; 22(4):1554-5. PubMed ID: 2389398
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C; Pascual M
    Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of CMV infection in transplant patients.
    Fishman JA
    Transpl Infect Dis; 1999; 1 Suppl 1():35-9. PubMed ID: 11565586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus infection after liver transplantation.
    Chen YS; Chen CL; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):2229-30. PubMed ID: 8066728
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current methods of anti-infectious prophylaxis in patients with HIV infection].
    Mayaud C; Parrot A; Cadranel J
    Rev Mal Respir; 1994; 11(4):433-5. PubMed ID: 7973047
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic cytomegalovirus management strategies.
    Martin M
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):23-7. PubMed ID: 7482812
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis of infection in bone marrow transplants.
    Winston DJ; Ho WG; Gale RP; Champlin RE
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S15-23. PubMed ID: 3127217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
    Puius YA; Snydman DR
    Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for cytomegalovirus prophylaxis in solid organ transplantation.
    Snydman DR
    Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of cytomegalovirus in organ transplantation].
    Aguado JM
    Rev Clin Esp; 1996 Apr; 196(4):240-7. PubMed ID: 8701064
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A; Russo D; Salmaso F
    Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G
    Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.